Skip to main content Accessibility help
×
Home

Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder

  • Xavier Benarous (a1) (a2), Vladimir Ferrafiat (a3) (a4), Jessica Zammit (a3) (a4), Angèle Consoli (a1) (a5), Priscille Gérardin (a3) (a4), Jean-Marc Guilé (a2) (a6) (a7) and David Cohen (a1) (a8)...
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

*Address correspondence to: Xavier Benarous, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, 83, boulevard de l’Hôpital, 75013 Paris, France. Tel: +33(0)142162380, Fax: +33(0)142162331. (Email: xavierbenarous@gmail.com)

References

Hide All
1. Benarous, X, Consoli, A, Guile, JM, et al. Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD. Eur Child Adolesc Psychiatry. 2017; 26(1): 523; doi: 10.1007/s00787-016-0907-5.
2. NICE. National Institute for Health and Care Excellence: Guidance. Attention Deficit Hyperactivity Disorder: Diagnosis and Management (NG87). Leicester: The British Psychological Society & The Royal College of Psychiatrists; 2018.
3. Moukhtarian, TR, Cooper, RE, Vassos, E, et al. Effects of stimulants and atomoxetine on emotional lability in adults: a systematic review and meta-analysis. Eur Psychiatry J Assoc Eur Psych. 2017; 44: 198207; doi: 10.1016/j.eurpsy.2017.05.021.
4. Lenzi, F, Cortese, S, Harris, J, et al. Pharmacotherapy of emotional dysregulation in adults with ADHD: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018; 84: 359367; doi: 10.1016/j.neubiorev.2017.08.010.
5. Jou, RJ, Handen, BL, Hardan, AY. Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005; 15(2): 325330; doi: 10.1089/cap.2005.15.325.

Keywords

Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder

  • Xavier Benarous (a1) (a2), Vladimir Ferrafiat (a3) (a4), Jessica Zammit (a3) (a4), Angèle Consoli (a1) (a5), Priscille Gérardin (a3) (a4), Jean-Marc Guilé (a2) (a6) (a7) and David Cohen (a1) (a8)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed